Resveratrol reverts Streptozotocin-induced diabetic nephropathy

被引：12
|
作者：
Zhu, Huiping [1 ,2 ]
Zhong, Sen [1 ,2 ]
Yan, Haihong [1 ,2 ]
Wang, Kangyao [1 ,2 ]
Chen, Lingwei [1 ,2 ]
Zhou, Min [1 ,2 ]
Li, Yunsheng [1 ,2 ]
机构：
[1] Wenzhou Med Univ, Peoples Hosp Wenling 1, Dept Nephrol, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Wenling Hosp, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2020年 / 25卷
关键词：
Resveratrol; Renal dysfunction; Diabetic nephropathy; mTOR/ULK1; pathway; Autophagy; RENAL LIPID-METABOLISM; PODOCYTE FUNCTION; AUTOPHAGY; MICE; ACCUMULATION; PROGRESSION; PROTECTS; FIBROSIS; TARGET; MTOR;
D O I：
10.2741/4829
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes causes diabetic nephropathy (DN) which is associated with increased morbidity and mortality in diabetic patients. We tested whether Resveratrol (Res) reverses the systemic effect of Streptozotocin (STZ) induced diabetes and DN. Res treatment opposed the effect of STZ on kidney weight, 24 h urinary albumin excretion, blood urea nitrogen (BUN) and serum creatinine (Scr). Res also decreased DN induced mTOR/ULK1-mediated autophagy and apoptosis and significantly reduced STZ mediated lipid deposition in nephrons, likely by decreasing the levels of lipogenic related proteins (SREBP-1c, ACS) and increased lipidolysis related proteins (PPAR alpha, CPT-1). Together, these findings show the potential of Res in prevention of diabetic nephropathy.
引用
收藏
页码：699 / 709
页数：11
相关论文
共 50 条
  • [41] EFFECT OF CICAPROST ON THE PROGRESSION OF DIABETIC NEPHROPATHY IN UNINEPHRECTOMIZED STREPTOZOTOCIN-INDUCED DIABETIC RATS
    ROBLES, RC
    VILLA, E
    RABANO, A
    ALVAREZ, E
    MARTINEZ, L
    RUILOPE, LM
    SANCHO, JM
    JOURNAL OF HYPERTENSION, 1993, 11 : S208 - S209
  • [42] The Protective Effects of Carvedilol on Diabetic Nephropathy in A Streptozotocin-Induced Diabetic Rat Model
    Erdogan, Mumin Alper
    Yigitturk, Gurkan
    Erbas, Oytun
    ACTA PHYSIOLOGICA, 2019, 227 : 51 - 51
  • [43] Erythropoietin attenuates diabetic nephropathy beyond hematopoiesis in streptozotocin-induced diabetic rats
    Toba, H.
    Sawai, N.
    Morita, Y.
    Nakashima, K.
    Yoshida, M.
    Morishita, M.
    Kobara, M.
    Nakata, T.
    JOURNAL OF HYPERTENSION, 2008, 26 : S210 - S210
  • [44] Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats
    Yang, Dong Kwon
    Kang, Hyung-Sub
    BIOMOLECULES & THERAPEUTICS, 2018, 26 (02) : 130 - 138
  • [45] Resveratrol effects on streptozotocin-induced diabetes
    Kocaturk, P. Aribal
    Kavas, G. Ozelci
    TRACE ELEMENTS AND ELECTROLYTES, 2007, 24 (02) : 112 - 116
  • [46] THERAPEUTIC IMPACTS OF EPIGALLOCATHECIN GALLATE ON STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHY IN MICE
    Shin, Byung Chul
    Kim, Hyun Lee
    Chung, Jong Hoon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 171 - 171
  • [47] Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats
    Rupinder Kaur
    Rupinder Kaur Sodhi
    Neha Aggarwal
    Jaspreet Kaur
    Upendra K. Jain
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2016, 389 : 73 - 85
  • [48] The role of programmed cell death in streptozotocin-induced early diabetic nephropathy
    Wu, W-H.
    Zhang, M. -P.
    Zhang, F.
    Liu, F.
    Hu, Z. -X.
    Hu, Q. -D.
    Yan, X. -Y.
    Huang, S. -M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (09) : E296 - E301
  • [49] N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy
    Saito, Motoaki
    Kinoshita, Yukako
    Satoh, Itaru
    Shinbori, Chiko
    Kono, Tomoharu
    Hanada, Takuya
    Uemasu, Jiro
    Suzuki, Hiroto
    Yamada, Masashi
    Satoh, Keisuke
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 544 (1-3) : 132 - 137
  • [50] Effect of a polyherbal formulation in streptozotocin-induced diabetic nephropathy in wistar rats
    Reddy, Kanala Somasekhar
    Sudheer, Akkiraju
    Pradeepkumar, Bhupalam
    Reddy, Chappidi Suryaprakash
    INDIAN JOURNAL OF PHARMACOLOGY, 2019, 51 (05) : 330 - 336
12345